# A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet and Conventional Tablet Under With Water Intake

> **NCT01394653** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 36 (actual)

## Conditions studied

- Healthy
- Plasma Concentration of YM060

## Interventions

- **DRUG:** YM060

## Key facts

- **NCT ID:** NCT01394653
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-08
- **Final completion:** 2011-08
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2011-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01394653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01394653, "A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet and Conventional Tablet Under With Water Intake". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01394653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*